ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO1134

Kidney Function Decline Affects Endothelial Dependent Flow Mediated Dilation Independently of HDL, LDL, and HsCRP

Session Information

Category: CKD (Non-Dialysis)

  • 1902 CKD (Non-Dialysis): Clinical, Outcomes, and Trials


  • Whitfield, Victoria, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Akwo, Elvis A., Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Siew, Edward D., Vanderbilt University School of Medicine, Nashville, Tennessee, United States
  • Ikizler, Talat Alp, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Hung, Adriana, Vanderbilt University, Nashville, Tennessee, United States

Patients with CKD have a significant cardiovascular morbidity & mortality. Endothelial function is the earliest manifestation in the continuum of atherosclerosis. We investigated the relationship between glomerular filtration rate (GFR) and endothelium-dependent vascular function in a nondiabetic population.


Participants were 89 CKD patients and 22 with normal GFR who underwent brachial artery flow-mediated dilation (FMDBA) by high resolution ultrasound. Clinical evaluation, renal function tests, lipid profile and high sensitivity C-reactive protein (hsCRP) assays were performed on all study participants. Multivariable linear regression models with robust standard errors were used to investigate the dose-response relationship between FMD% and estimated GFR (eGFR) – modeled as a restricted cubic spline with 4 knots. Covariates were age, sex, race, body mass index (BMI), systolic blood pressure (SBP), hsCRP, HDL and LDL cholesterol. Skewed variables were log transformed.


Over 71% of participants were male, 21% were African-American. The mean (SD) age was 63.2 (13.7) years. Median (25th, 75th) FMD% was lower among CKD patients compared to controls [4.2 (2.9, 6.3) vs. 8.5 (4.8, 10.4); p = 0.0004] (figure 1). After full adjustment for baseline covariates, CKD patients had a significant 3.2% (95% CI: 0.7, 5.7, p = 0.01) lower FMD%. Percent FMD had a significant inverse correlation with age (r = -0.36, p = 0.001). In a minimal model adjusted for age, sex, race and BMI, eGFR had a significant (p = 0.0006) positive nonlinear relationship with FMD% with a trough on the dose-response curve occurring at an eGFR ~ 60mL/min/1.73m2 (figure 1). The association remained significant (p = 0.0005) after further adjustment for SBP, log hsCRP, log HDL and log LDL.


Endothelium-dependent vascular function diminishes across the kidney function continuum, independently of traditional CVD risk factors. Further investigation into the underlying mechanisms involved maybe warranted.


  • Veterans Affairs Support